Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Feasibility of spondyloplasty with SpineJack<sup>®</sup> implants in patients with thin vertebral pedicles.

European radiology·2026
Same author

Evaluating the Impact of Embolization on Outcomes in Iliopsoas Hematomas: A Multicenter Retrospective Propensity-matched Study.

Academic radiology·2026
Same author

Breast cryoablation: What does the current evidence allow us to say?

Diagnostic and interventional imaging·2026
Same authorSame journal

The Unseen Aneurysm: Can Artificial Intelligence Bridge the Diagnostic Gap in Angiogram-Negative Subarachnoid Hemorrhage?

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes·2026
Same author

Occupational radiation exposure and radiation protection practices in interventional radiology and cardiology: A multicenter study in France.

Diagnostic and interventional imaging·2026
Same author

The polystyrene beads sign: a simple MRI marker for the preoperative diagnosis of papillary hypothalamic craniopharyngiomas.

European journal of endocrinology·2026

相关实验视频

Updated: Jul 1, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

427

干预性瘤学:2024年更新更新

Ruben Geevarghese1, Sylvain Bodard1, Leo Razakamanantsoa2

  • 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes
|March 6, 2024
PubMed
概括
此摘要是机器生成的。

干预瘤学 (IO) 使用人工智能,个性化医学和成像创新来推进癌症护理. 这些技术提高了瘤检测,治疗精度和患者的结果,彻底改变了瘤学干预措施.

关键词:
干预性瘤学干预性瘤学干预性放射学 干预性放射学图像导航导航导航图像导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航导航

更多相关视频

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

相关实验视频

Last Updated: Jul 1, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

427
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.5K
Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
09:49

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

10.3K

科学领域:

  • 干预性瘤学干预性瘤学
  • 医疗成像医学成像
  • 人工智能在医学中的应用

背景情况:

  • 干预瘤学 (IO) 是一个快速发展的领域,正在改变癌症治疗.
  • 它集成了先进的成像技术和创新的微创手术.
  • 技术进步是其在患者护理中不断扩大作用的关键.

研究的目的:

  • 审查干预瘤学的最新发展和未来潜力.
  • 突出人工智能,个性化医疗和成像创新的影响.
  • 讨论程序技术的进步和以患者为中心的结果.

主要方法:

  • 这项研究是对干预瘤学近期发展的叙述性回顾.
  • 它合成了关于人工智能,个性化医疗,先进成像和程序创新的信息.
  • 该审查还考虑了培训,劳动力能力和患者的结果.

主要成果:

  • 人工智能 (AI) 集成加速瘤检测,表征和治疗策略的完善.
  • 先进的成像 (fMRI,PET,圆束CT) 和导航技术 (AR,机器人) 提高了程序的精度.
  • 栓塞和废除疗法的发展,以及基因组学,使治疗个性化并改善以患者为中心的结果.

结论:

  • 干预瘤学受到人工智能,个性化医学和成像创新的显著增强.
  • 技术进步有望通过提高准确性和患者结果,彻底改变癌症护理.
  • 干预放射科医生与新技术之间的协同作用对于推进癌症治疗至关重要.